Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Annals of Diagnostic Pathology

• Publication date

  2000-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1092-9134(00)90042-XPMID 10919389
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early glomerular lesions in amyloidosis

  2004cited by this paper
• Plasma cell myeloma

  2001cited by this paper
• Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1.

  1999cited by this paper
• Glomerulopathic light chain-mesangial cell interactions modulate in vitro extracellular matrix remodeling and reproduce mesangiopathic findings documented in vivo.

  1999cited by this paper
• The kidney in plasma cell dyscrasias: Bence-Jones cast nephropathy and light chain deposit disease.

  1998cited by this paper
• In vitro modulation of AL-amyloid formation by human mesangial cells exposed to amyloidogenic light chains.

  1998cited by this paper
• Renal Biopsy as a Primary Diagnostic Tool in Plasma Cell Dyscrasias

  1998cited by this paper
• Myeloma light chains are ligands for cubilin (gp280).

  1998cited by this paper
• Complete primary sequences of two lambda immunoglobulin light chains in myelomas with nonamyloid (Randall-type) light chain deposition disease.

  1998cited by this paper
• Myeloma light chains are ligands for cubilin (gp280).

  1998cited by this paper
• Receptor-mediated endocytosis of immunoglobulin light chains by renal proximal tubule cells.

  1997cited by this paper
• TGF-beta in kidney fibrosis: a target for gene therapy.

  1997cited by this paper
• Immunoglobulin light chain alters mesangial cell calcium homeostasis.

  1997cited by this paper
• Domain stability in immunoglobulin light chain deposition disorders.

  1997cited by this paper
• Integrated expression of glomerular extracellular matrix proteins and beta 1 integrins in monoclonal light chain-related renal diseases.

  1997cited by this paper
• TGF-β in kidney fibrosis: A target for gene therapy

  1997cited by this paper
• Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.

  1996cited by this paper
• Structural peculiarities of a truncated VκIII immunoglobulin light chain in myeloma with light chain deposition disease

  1996cited by this paper
• Structural peculiarities of a truncated V kappa III immunoglobulin light chain in myeloma with light chain deposition disease.

  1996cited by this paper
• In vitro AL-amyloid formation by rat and human mesangial cells.

  1996cited by this paper
• Molecular therapy for renal diseases.

  1996cited by this paper
• De novo light-chain deposition disease in a cadaver renal allograft.

  1996cited by this paper
• Protein Chemistry: Misfolding the Way to Disease

  1996cited by this paper
• Biochemical interaction between Tamm-Horsfall glycoprotein and Ig light chains in the pathogenesis of cast nephropathy.

  1995cited by this paper
• Protein and host factors implicated in the pathogenesis of light chain amyloidosis (AL amyloidosis)

  1995cited by this paper
• Treatment of amyloidosis.

  1995cited by this paper
• A molecular model for self-assembly of amyloid fibrils: immunoglobulin light chains.

  1995cited by this paper
• Pathogenesis of glomerulosclerosis in light chain deposition disease. Role for transforming growth factor-beta.

  1995cited by this paper
• Growth factors in monoclonal light-chain--related renal diseases.

  1994cited by this paper
• Monoclonal immunoglobulin deposition disease: a review of immunoglobulin chain alterations.

  1994cited by this paper
• A role for destabilizing amino acid replacements in light-chain amyloidosis.

  1994cited by this paper
• Pathogenesis and treatment of myeloma kidney.

  1994cited by this paper
• Ultrastructural immunolabeling: a unique diagnostic tool in monoclonal light chain-related renal diseases.

  1994cited by this paper
• Low molecular weight proteins and the kidney: physiologic and pathologic considerations.

  1994cited by this paper
• Light chain deposition disease (nodular glomerulopathy, kappa light chain deposition disease): a case report.

  1994cited by this paper
• Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains.

  1994cited by this paper
• Monoclonal immunoglobulin light chain-related renal diseases.

  1993cited by this paper
• Brief report: heavy-chain deposition disease.

  1993cited by this paper
• Heavy-Chain Deposition Disease

  1993cited by this paper
• Tamm-Horsfall glycoprotein binds IgG with high affinity.

  1993cited by this paper
• Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease.

  1992cited by this paper
• Fifteen years' experience with renal transplantation in systemic amyloidosis

  1992cited by this paper
• Primary structure of a monoclonal kappa chain in myeloma with light chain deposition disease.

  1992cited by this paper
• TGF-β: Regulation of extracellular matrix

  1992cited by this paper
• Pathobiology of cast nephropathy from human Bence Jones proteins.

  1992cited by this paper
• Primary structure of a monoclonal κ chain in myeloma with light chain deposition disease

  1992cited by this paper
• TGF-beta: regulation of extracellular matrix.

  1992cited by this paper
• Nephrotoxic potential of Bence Jones proteins.

  1991cited by this paper
• Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition.

  1991cited by this paper
• Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988.

  1991cited by this paper
• Animal Cell Culture

  1990cited by this paper
• Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins.

  1990cited by this paper
• Immunoglobulin heavy-chain-associated amyloidosis.

  1990cited by this paper
• Urinary excretion of kappa light chains in patients with diabetes mellitus.

  1990cited by this paper
• Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.

  1990cited by this paper
• Outcome of end-stage renal disease in patients with rare causes of renal failure. II. Renal or systemic neoplasms.

  1989cited by this paper
• Light chain deposition disease derived from the kappa I light chain subgroup. Biochemical characterization.

  1989cited by this paper
• Cytoplasmic crystals in multiple myeloma-associated Fanconi's syndrome. A morphological study including immunoelectron microscopy.

  1989cited by this paper
• The Kidney in Plasma Cell Dyscrasias

  1988cited by this paper
• Implications of renal failure in multiple myeloma

  1988cited by this paper
• Myeloma cast nephropathy: immunohistochemical and lectin studies.

  1988cited by this paper
• Isotypy of serum monoclonal immunoglobulins in human immunodeficiency virus-infected adults.

  1988cited by this paper
• Morphologic alterations of the proximal tubules in light chain-related renal disease.

  1988cited by this paper
• Differential nephrotoxicity of low molecular weight proteins including Bence Jones proteins in the perfused rat nephron in vivo.

  1988cited by this paper
• Controlled plasma exchange trial in acute renal failure due to multiple myeloma.

  1988cited by this paper
• Human Bence Jones protein toxicity in rat proximal tubule epithelium in vivo.

  1987cited by this paper
• Management of myeloma kidney: an anti-light-chain approach.

  1987cited by this paper
• Multiple Myeloma and Severe Renal Failure: A Clinicopathologic Study of Outcome and Prognosis in 34 Patients

  1987cited by this paper
• Light chain cast nephropathy and acute renal failure associated with rifampin therapy. Renal disease akin to myeloma kidney.

  1987cited by this paper
• Aberrant immunoglobulin synthesis in light chain amyloidosis. Free light chain and light chain fragment production by human bone marrow cells in short-term tissue culture.

  1986cited by this paper
• Ultrastructural immunolabeling in the diagnosis of light-chain-related renal disease.

  1986cited by this paper
• Isoelectric points of urinary light chains in myelomatosis: analysis in relation to nephrotoxicity.

  1986cited by this paper
• Renal transplantation in light chain nephropathy: case report and review of the literature.

  1986cited by this paper
• RENAL TRANSPLANTATION IN 45 PATIENTS WITH AMYLOIDOSIS

  1986cited by this paper
• A review of light, polarization and fluorescence microscopic methods for amyloid.

  1985cited by this paper
• IgM monoclonal gammopathy accompanied by nodular glomerulosclerosis, urine-concentrating defect, and hyporeninemic hypoaldosteronism.

  1985cited by this paper
• Effect of urinary pH and diatrizoate on Bence Jones protein nephrotoxicity in the rat.

  1985cited by this paper
• Renal failure in myeloma: relationship with isoelectric point of immunoglobulin light chains.

  1984cited by this paper
• Rapidly progressive ('crescentic') glomerulonephritis and monoclonal gammapathies.

  1984cited by this paper
• Light-chain deposition disease: its relation with AL-type amyloidosis.

  1984cited by this paper
• Myeloma kidney cast nephropathy in a rat model of multiple myeloma.

  1983cited by this paper
• Nature of intracytoplasmic crystalline inclusions in myeloma cells (morphologic, cytochemical, ultrastructural, and immunofluorescent studies).

  1983cited by this paper
• From the first to the last of the immunoglobulins. Perspectives and prospects.

  1983cited by this paper
• Renal lesions in multiple myeloma: their relationship to associated protein abnormalities.

  1983cited by this paper
• Amyloidosis.

  1982cited by this paper
• Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda).

  1982cited by this paper
• Crystalline tissue deposits on a case of multiple myeloma.

  1981cited by this paper
• Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-1981.

  1981cited by this paper
• Proliferative glomerulonephropathy in multiple myeloma

  1980cited by this paper
• Nonamyloid green birefringence following Congo red staining.

  1980cited by this paper
• Multiple myeloma: a clinicopathologic study of 62 consecutively autopsied cases.

  1980cited by this paper
• Synthesis of abnormal immunoglobulins in lymphoplasmacytic disorders with visceral light chain deposition.

  1980cited by this paper
• Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin.

  1980cited by this paper
• Nonamyloid green birefringence following Congo red staining.

  1980cited by this paper
• Pathophysiology of Tamm-Horsfall protein.

  1979cited by this paper
• Nephrotoxicity of Bence Jones proteins in the rat: importance of protein isoelectric point.

  1979cited by this paper
• Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo.

  1978cited by this paper
• Glomerular filtration of proteins: clearance of anionic, neutral, and cationic horseradish peroxidase in the rat.

  1978cited by this paper
• RENAL FUNCTION IN PATIENTS WITH MULTIPLE MYELOMA

  1978cited by this paper
• Monoclonal gammopathy of undetermined significance. Natural history in 241 cases.

  1978cited by this paper

• Outcomes in Patients With Multiple Myeloma and Prescribed Urate-Lowering Therapy: A Propensity-Matched Study

  2025cites this paper
• Features that characterize monoclonal light chain (“myeloma”) cast nephropathy with immunofluorescence challenges and emphasis on electron microscopy

  2024cites this paper
• The role of therapeutic plasma exchange in plasma cell disorders

  2024cites this paper
• Clinicopathological Profile of Paraprotein-Associated Kidney Disease in Monoclonal Gammopathies: An Observational Study

  2022cites this paper
• Light Chain Restriction in Proximal Tubules—Implications for Light Chain Proximal Tubulopathy

  2022cites this paper
• Glomerulopathic Light Chain-Mesangial Cell Interactions: Sortilin-Related Receptor (SORL1) and Signaling

  2021cites this paper
• Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease

  2020cites this paper
• The pathogenesis of renal injury and treatment in light chain deposition disease

  2019cites this paper
• Pathophysiology and management of monoclonal gammopathy of renal significance.

  2019cites this paper
• An Unusual Case of Lysosomal Paraprotein Accumulation in Glomerular Endothelial Cells

  2019cites this paper
• Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies

  2018cites this paper
• Effects of intratesticular injection of zinc-based solution in rats in combination with anti-inflammatory and analgesic drugs during chemical sterilization

  2018cites this paper
• The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

  2018cites this paper
• A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease

  2018cites this paper
• Amyloid Proximal Tubulopathy and Amyloid Casts: An Unusual Finding in Multiple Myeloma

  2018influential citation
• AKI in Multiple Myeloma: Paraproteins, Metabolic Disturbances, and Drug Toxicity

  2017cites this paper
• The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases.

  2017cites this paper
• [Uromodulin gene polymorphisms in patients with cast nephropathy in multiple myeloma].

  2017cites this paper
• Healing the damaged mesangium in nodular glomerulosclerosis using mesenchymal stem cells (MSCs): Expectations and challenges

  2016cites this paper
• Animal Models of Light Chain Deposition Disease Provide a Better Understanding of Nodular Glomerulosclerosis

  2016cites this paper
• Renal Manifestations of Plasma Cell Neoplasms

  2016cites this paper
• Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?

  2016cites this paper
• New aspects on the pathogenesis of renal disorders related to monoclonal gammopathies.

  2015cites this paper
• Circulating Monoclonal Light Chains and Acute Kidney Injury: The Role of the Renal Biopsy with Emphasis on Ultrastructural Evaluation in Assessing and Understanding Renal Injury

  2015cites this paper
• Direct Immunofluorescence of Renal Biopsy: Perspective of an Immunopathologist

  2015cites this paper
• An animal model of glomerular light-chain-associated amyloidogenesis depicts the crucial role of lysosomes.

  2014cites this paper
• Understanding Mesangial Damage and Repair: Insights from an Experimental Model of Immunoglobulin Light Chain-Associated Mesangiopathy

  2014cites this paper
• Proximal tubulopathies associated with monoclonal light chains: the spectrum of clinicopathologic manifestations and molecular pathogenesis.

  2014cites this paper
• Proliferative glomerulonephritis with monoclonal immunoglobulin deposits in a kidney allograft.

  2014cites this paper
• Multiple Myeloma and the Kidney

  2013cites this paper
• Contribution of Polyclonal Free Light Chain Deposition to Tubular Injury

  2013cites this paper
• The biology of immunoglobulin free light chains in kidney disease: a study of Monoclonal and Polyclonal light chains

  2012cites this paper
• Light Chain Proximal Tubulopathy: Expanding the Pathologic Spectrum with and without Deposition of Crystalline Inclusions

  2012cites this paper
• Systemic and rapidly progressive light-chain deposition disease initially presenting as tubulointerstitial nephritis

  2012cites this paper
• Light/Heavy Chain Deposition Disease as a Systemic Disorder

  2012cites this paper
• The pathogenesis and diagnosis of acute kidney injury in multiple myeloma

  2012cites this paper
• Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach

  2011cites this paper
• Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience.

  2011influential citation
• The biology of immunoglobulin free light chains and kidney injury.

  2011cites this paper
• Light chain deposition disease in kidney: A review of the literature

  2011cites this paper
• Ultrastructural Immunolabeling in the Diagnosis of Monoclonal Light-and Heavy-chain-related Renal Diseases

  2010influential citation
• Renal diseases with organized deposits: an algorithmic approach to classification and clinicopathologic diagnosis.

  2010cites this paper
• Safety and efficacy of bortezomib‐based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA

  2010cites this paper
• Plasma cell dyscrasia causing light chain tubulopathy without Fanconi syndrome.

  2010cites this paper
• Renal lesions associated with plasma cell dyscrasias: practical approach to diagnosis, new concepts, and challenges.

  2009cites this paper
• Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration

  2009cites this paper
• Immunotactoid Microtubular Corneal Deposits in Bilateral Paraprotein Crystalline Keratopathy

  2009cites this paper
• Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia.

  2009cites this paper
• An in vitro model of light chain deposition disease.

  2009cites this paper
• Proximal tubule cytoplasmic fibrillary inclusions following kidney transplantation in a patient with a paraproteinemia.

  2009cites this paper
• Light-chain-mediated acute tubular interstitial nephritis: a poorly recognized pattern of renal disease in patients with plasma cell dyscrasia.

  2009cites this paper
• Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.

  2008cites this paper
• Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.

  2008cites this paper
• Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.

  2007cites this paper
• A history of the kidney in plasma cell disorders.

  2007cites this paper
• The mesangium as a target for glomerulopathic light and heavy chains: pathogenic considerations in light and heavy chain-mediated glomerular damage.

  2007cites this paper
• Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy.

  2007cites this paper
• High-dose therapy in patients with plasma cell dyscrasias and renal dysfunction.

  2007cites this paper
• Role of translational research advancing the understanding of the pathogenesis of light chain‐mediated glomerulopathies

  2007cites this paper
• Plasma Cell Dyscrasia with Kappa Light-chain Crystals in Proximal Tubular Cells: A Histological, Immunofluorescent, and Ultrastructural Study

  2006cites this paper
• Absence of renal lesions in C57BL/KaLwRij mice with advanced myeloma due to 5T2MM cells.

  2006cites this paper
• Renal pathology and retinol status in multiple myeloma patients.

  2006cites this paper
• Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage.

  2005cites this paper
• Clinical Features of Renal Insufficiency due to Multiple Myeloma and Related Risk Factors

  2005influential citation
• Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns

  2004cites this paper
• Pathogenesis of Renal AL-Amyloidogenesis (AL-AM): An In-Vitro Approach to Understanding Mechanisms Involved

  2004cites this paper
• AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells

  2004cites this paper
• Renal Diseases Associated With Multiple Myeloma and Related Plasma Cell Dyscrasias

  2004cites this paper
• Electron microscopy of renal disease

  2004cites this paper
• Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns

  2004cites this paper
• Atypical Amyloidosis: Diagnostic Challenges and the Role of Immunoelectron Microscopy in Diagnosis

  2004cites this paper
• Organized Deposits in the Kidney and Look-Alikes

  2003cites this paper
• Organized deposits in the kidney and look-alikes.

  2003cites this paper
• Insights into Mechanisms Responsible for Mesangial Alterations Associated with Fibrogenic Glomerulopathic Light Chains

  2003cites this paper
• Urinary excretion of retinol in patients with multiple myeloma: A preliminary study

  2003cites this paper
• The contributions of electron microscopy to the understanding and diagnosis of plasma cell dyscrasia-related renal lesions

  2001cites this paper